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PSEUDOMONAS INTRODUCTION 
 
 The discovery of the antibiotic penicillin by Alexander Fleming in 1928 
eventually led to the formal treatment of disease with such microbial derived drugs 
(Wong, 2003).  Penicillin is a natural product, and scientists have continued to search 
natural sources for new and effective medicinal compounds. Today almost half of the 
drugs used to treat disease have their roots in natural products (Dewick, 2002). 
Nevertheless, some pathogens still go untreated and others have developed resistance to 
known remedies, creating a constant need for new treatment methods.  
 As the demand for novel remedies continues, natural products are still an 
important source of new medicines.  Natural products, sometimes known as secondary 
metabolites, are defined as compounds that do not appear to be essential to the life of the 
producing organism, but which may serve some other defensive, or anti-predatory role 
(Malik, 1980; DeLisa, 2002).  Often these secondary metabolites are found to be 
organism specific and vary structurally under different growth conditions.  In most cases, 
the biosynthetic building blocks for these secondary metabolites are derived from 
primary metabolites such as organic acids, amino acids, and carbohydrates leading to a 
wide range of structures.  In microbes, secondary metabolite production is most often 
suppressed during the lag and exponential phases of growth and is greatest during the 
stationary phase when the highest concentration of primary metabolism side products is 
present (Malik, 1980).  
 Based on their biosynthetic origin, secondary metabolites are classified into five 
main classes of natural products: polyketides, terpenes, shikimates, peptides, and 
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alkaloids.  Each class has specific structural and biological characteristics and represent 
many of the beneficial products used in today’s society. One of the most common types 
of natural products are the polyketides.  These compounds are derived from simple 
organic acid units such as acetic acid, pyruvic acid, and butyric acid (Pfeifer, 2001; 
Hopwood).  These acids are condensed on a large multifunctional enzyme called a 
polyketide synthase (PKS) to form β-keto chains that can be further modified (Simpson, 
1995).  Two examples of bioactive polyketides are pseudomonic acid A (1) (Figure 1A) 
and dynemycin (2) (Figure 1B). Pseudomonic acid A, produced by Pseudomonas 
fluorescens, is active against methicillian resistant Staphylococcus aerus (MRSA) 
infections while dynemycin, produced by Micromonospora chersina, acts as an anti-
cancer agent (Mantle, 2001; Simpson, 1995).  Further examples include the antibiotic 
tetracycline (3) (Figure1C) and lovastatin (4) (Figure 1D), an effective cholesterol-
lowering agent. Tetracycline is produced by Streptomyces texas, while lovastatin is 
produced by Aspergillus terreus (Brodersen, 2000). 
Another major class of natural products are the terpenes, which are derived from 
the isoprene moiety, a five-carbon unit.  This isoprene unit is formed via the mevalonic 
acid (mevalonic pathway) or deoxyxylulose (deoxyxylulose pathway) and in most cases 
these units are assembled in a regular head-to-tail manner.  This biosynthetic pathway can 
results in a variety of molecules called monoterpenes (C10), sesuiterpene (C15), diterpenes 
(C20), triterpenes (C30) and teraterpenes (C40). The sesterterpenes (C25) are  
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Figure 1:        Polyketide Secondary Metabolites from Pseudomonas fluorescens 
A) Pseudomonic Acid A (1) 
B) Dynemycin (2) 
C) Tetracycline (3) 
D) Lovastatin (4) 
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assembled from five isoprene units (Dewick, 2002) and two examples of this class that 
are produced by Centella asiatica (Jew, 2000) are asiatic acid (5) and madecassic acid (6) 
(Figure 2A).  Each of these is used to decrease the wound area of skin necrosis induced 
by flesh burns (Cho, 2003).  
The next group is known as the shikimates, which are ubiquitous in 
microorganisms and in plants.  This group of compounds includes secondary metabolites 
containing aromatic amino acids, which in turn are derived from shikimic acid (Dewick, 
2002).  An example of a bioactive shikimate, is secoisolariciresinol (7) (Figure 2B). This 
molecule belongs to the lignan group of compounds and is commonly found in flax 
seeds.  Secoisolariciresinol has been found to bind to human sex hormone binding 
globulin (SHBG), which is helpful in the treatment of benign prostatic hyperplasya 
(Eliasson, 2003).  
 Another important group of natural products are the peptides, which are formed 
from a wide variety of protein and non-protein amino acid units.  Typically these are 
oligomers of amino acids that are combined in either a linear or cyclic manner and are 
assembled by a process that does not require a ribosome (Dewick, 2002).  Consequently, 
these compounds are called non-ribosomal peptides. Vancomycin (8) is typical of such a 
bioactive peptide (Figure 2C), and is produced by Streptomyces orientalis.  This 
compound functions as an important therapeutic against multiple-resistant gram-positive 
bacteria and is of specific use against bacteria with ampicillian or methicillin resistance 
(Klare, 2003).  
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Lastly, the alkaloids are organic nitrogenous bases found mainly in plants, but are 
also found in animals and microorganisms to a lesser extent.  Alkaloids contain one or 
more nitrogen atoms and can be of any hybridization.  The main constituents of alkaloids  
are shikimic acid, acetate, and mevalonic acid (Dewick, 2002). Each of these constituents 
can be combined in a various manner to produce an alkaloid.  A common example of an  
alkaloid produced by plants in the Ephedra genus is ephedrine (9) (Figure 2D), which is 
commonly used as a nasal decongestant or to treat bronchial asthma.   
 As the search for new drugs continues, scientists are exploring novel treatment 
methods.  This is particularly true in the search for new anti-infectives, and one approach 
is to find molecules that interfere with the growth or virulence of infectious 
microorganisms. It was discovered that the marine bacterium Vibrio fisheri uses small 
molecules as a means of cell-to-cell communication to produce bioluminescence (Wolf-
Watz, 2003).  These molecules were named quorum sensing compounds or autoinducers. 
Quorum sensing is an environmental sensing system that allows bacteria to monitor their 
own population density.  Specifically, bacteria produce autoinducers that allow the 
activation of certain transcription factors at high cell concentrations (Figure 3) (Loh, 
2002) and such compounds have been found to regulate virulence, production of 
secondary metabolites, symbiosis, biofilm formation, and individual survival strategies 
(Bauer, 2002; Withers, 2001). A variety of different signaling compounds have been 
reported from different microbes (Figure 4). Typically gram-negative bacteria such as P. 
fluorescens use N-acyl homoserine lactones (AHLs), such as N-hexanoyl- HSL (10) and 
N-(3-oxo-octanoyl)- HSL (11), as cell-signaling  
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Figure 2:        Further Examples of Bioactive Natural Products 
A)  Asiatic Acid (5) and Madecassic Acid (6) 
B)  Secoisolariciresinol (7) 
C)  Vancomycin (8) 
D)  Ephedrine (9) 
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Figure 3:        A simplified scheme for the AHL-mediated autoinduction by I and R  
            proteins.  
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Figure 4:        Examples of Quorum Sensing Compounds 
A) N-hexanoyl-L HSL (10)  
B) N-(3-oxo-octanoyl)-L-HSL (11) 
C) cyclo (∆Ala-L-Val) (12) 
D) cyclo (L-Phe-L-Pro) (13) 
E) 2-heptyl-3-hydroxy-4-quinolone (14) 
                      F)     oligopeptide (15) 
G)   oligopeptide (16)  
H)   3-hydroxypalmitic acid methyl ester (17) 
                       I)     4-bromo-5(bromomethlene)-3-1’-hydroxybutyl-2(5H)-furanone (18) 
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compounds, though other autoinducers are known to exist among the Pseudomonas 
genera and include diketopiperazines (DKPs) and Pseudomonas quinolone signal (PQS) 
(14) (Brelles-Marino, 2001; Holden, 1999). Besides the Pseudomonads, other organisms 
produce unique classes of cell-signaling molecules, and Staphlococcus aureus produces a 
roup of oligopeptides such as those seen in Figure 4 (Donabedian, 2002; Schauder, 
2001). On the other hand, a group of furanones produced by Delisea pulchra and 
Xanthomonas  act as antagonists to these known 
autoinducers 
nducers are the AHLs, which all consist of a 
The fatty acyl side chain can be four to fourteen carbons in length and may be saturated 
or unsaturated (Whitehead, 2001).  Due to this variability in the length of the side chain, 
different methods of AHL transportation can operate. Short-chain acyl homoserine 
lactone (HSL) molecules are capable of passively diffusing across bacterial membranes, 
whereas long-chain acyl-HSLs are actively transported.  Another site of variability in the 
side chain of AHLs is the presence of a hydroxyl or keto group at the C-3 position (Loh, 
2002).   
 As the number of cells increase, AHLs accumulate until sufficient intracellular 
AHL is present to bind to the R protein, luxR, a transcriptional activator. The R protein is 
a 250 amino acid polypeptide and contains a carboxy-terminal region that is required for 
binding to a 20-basepair palindromic DNA sequence (lux box).  Another structural 
feature of the R protein that is critical to its function, is the amino-terminus. This portion 
of the molecule is found to inhibit the lux box when AHL is unbound and contains the 
g
 campestris have been found to
(Whitehead, 2001).  
The m cost ommon type of autoi
homoserine lactone ring containing a variable fatty acyl side chain (Schauder, 2001).  
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actual AHL binding site (Loh, 2002).  Specifically, the membrane-bound R protein 
receives incoming AHL signals, whereupon it undergoes a conformational change into 
the active form and after dimerization enters the cytoplasm to activate the lux box 
(Withers, 2001; Whitehead, 2001). The lux box is required for the lux gene expression 
and for the autoinduction response.  This sequence of events is seen as a potential 
"therapeutic target for the design of small molecular antagonists capable of attenua
virulence through the blockade of bacterial cell-to-cell communication" (William
 Pseudomonas fluorescens h
ting 
s, 2002). 
as been found to produce a wide variety of natural 
produc  that 
 
l 
o) (13) (Figure 5B) is a common quorum sensing compound produced by 
n 
 a 
ts or secondary metabolites (Fakhouri, 2001).  Of most interest are compounds
act as antibiotics, antifungal agents, and cell-signaling compounds.  The most common
antibiotic produced by P. fluorescens, namely pseudomonic acid A (1), is used as a 
topical treatment for methicillin resistant Staphylococcus aureus (MRSA) infections of 
burn patients and other dermal infections. Another bioactive product is the antifunga
agent 2,4-diacetylphloroglucinol (2,4-DAPG) (19) (Figure 5A).  Not only is this 
compound active against soilbourne fungal plant pathogens, but it has also been found to 
be active against Staphylococcus infections (Bangera, 1999).  The diketopiperazine, (L-
Phe-L-Pr
Pseudomonas fluorescens and acts as an antagonist of 3-oxo-C6-HSL mediated inductio
of bioluminescence.  This infers its ability to compete for the LuxR-binding site (Holden, 
1999).   Besides these bioactive agents, several compounds have been isolated that act as 
regulators, but do not act as anti-infectives.  For example, exopolysaccharide (20) is
carbohydrate that is produced by a variety of Pseudomonas fluorescens strains (Osman,  
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Figure 5:       Common Examples of Bioactive Compounds from Pseudomonas   
A) 2,4-DAPG (19) 
B) cyclo (L-Phe-L-Pro) (13) 
              C)    Pyoverdin (21) 
     2,4-Diacetylphloroglucinol (19)           B:     cyclo (L-Phe-L-Pro) (1
 
 
 
 
 
           fluorescens 
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1997).  Also, a few compounds have been found to act as siderophores, compounds that 
chelate Fe3+ and transport this into the cell.  The most common example of this is 
pyoverdin (21) (Figure 5C), a fluorescent yellow-green peptide. This unusual linear 
peptide contains a dihydroxyquinoline chromophore that is linked to the peptide chain by 
an amide bond (Ongena, 2001; Mossialos, 2000; Philson, 1982).  All of these compounds 
mentioned in this brief overview are examples of how natural products have benefited 
umankind and underscore the immense potential of natural products as medicinal 
therapeutics. 
 ti e med
Pseudomonas fluorescens as a source of bioactive secondary metabolites was pursued. As 
previously mentioned several compounds have been isolated from this bacterium, some 
of which act as antibacterial agents and quorum sensing molecules. Specifically, this 
study focused on the discovery of compounds that modulate the quorum sensing system 
of bacteria.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
h
Due to the increasing need for effec v icinal agents, the study of 
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PSEUDOMONAS EXPERIMENTAL 
 
ined 
ith a 
tector using a Phenomenex Luna C18 column (4.6 x 250 mm). Analytical 
lipse C18 
 
ing 
leco). Thin layer chromatography (TLC) was performed using Macherey-
Nagel Polygram Sil/UV plates, and visualiza on with vanillin/H2SO4 spray (Appendix 
1).  All chemicals were HPLC grade (Fisher or Aldrich). Concentration under reduced 
pressure was performed using a Buchi rotoevaporator modal R3000 or using a Savant 
speedvac model SC210A. Bioassay agar was cens agar (Difco) and the bioassay 
disks were from S & S Biopath, Inc. (0.25” diameter). 
Pseudomonas fluorescens Cultures 
 Pseudomonas fluorescens NCIB 10586 was maintained in both the labs of Dr. 
Sizemore and Dr. Wright. NCIB 10586 was maintained on both Pseudomonas 
General  
 1H NMR, 13C NMR, DEPT, COSY, HMQC, and TOCSY spectra were obta
in CDCl3 using a Bruker 500 MHz (BBO probe). For gas chromatography/mass 
spectrometry an HP 5890 series II gas chromatograph (Hewlett Packard, USA) with a 
30.0 m x 0.32 mm DB-5 cross-linked 5% phenyl-95% methyl polysiloxane column (film 
thickness-0.25 µm) was coupled with an HP 5871 series mass selective detector. Semi-
preparative HPLC was performed using a Waters 1040 gradient controller coupled w
Waters UV de
HPLC was performed carried out on a Hewlett Packard 1100 using a Vydac Ec
column (2.0 x 125 mm). Mass spectral data was collected on a Waters Micromass mass 
spectrometer using an electrospray probe. Open column chromatography was carried out
using either Bakerbond Octadecyl (C18) 40 µm Prep packing or Sephadex LH-20 pack
in 30 x 1 cm glass columns. Initial separation was done on 10 g/60 ml ENVI-18 Sep-pak 
columns (Sup
ti
 P. fluores
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fluorescens agar supplemented with ampicillian (100µg/ml) and brain heart infusion agar. 
All slants were stored at ree weeks. 
loopful of Pseudomonas fluorescens was used to inoculate 25 ml LB broth. 
 
lture.  
2 4 2 4
4 2 4 0 
was placed on each agar plate.  The broth was spread evenly on the plate using sterile 
(MeOH) and an aliquot (20 l) of each fraction was placed on a bioassay disk.  Each disk 
was allowed to dry for three hours and each disk was placed on the inoculated agar plates 
upside down.  The plates were then incubated for 24 hours at 37°C. Zones of inhibition 
were monitored. 
Cell-Signaling Assay  
All fractions tested for cell-signaling activity were carried out in the Pesci lab at 
Eastern Carolina University School of Medicine. Activity was determined using a 
standard β-galactosidase assay were the activity was measured in Miller units: 
  
15° C and slants were transferred every th
 A 
This was placed on a stir plate at 25°C and stirred at a medium speed for 24 hours.  Then
25 ml mupirocin production medium (MPM) was inoculated with 1.25 ml seed cu
In a 4 L Erlenmeyer flask, 2 L MPM was grown at 25°C on a stir plate for 48 hours. 
 The MPM consisted of yeast extract (2.3 %), Na HPO  (2.6%), KH PO  (2.4 %), 
(NH ) SO  (5.0 %), glucose (1.1 %), in distilled water.  Sterilization was at 121°C for 2
minutes. Media was allowed to cool for at least 24 hours before inoculation. 
Bioassay Procedure 
 A loopful of either E. coli or B. subtilis was placed in a corresponding vial of LB 
broth and was incubated at 37°C for 24 hours.  After incubation, 30 µl of bacterial broth 
techniques. Each fraction to be tested was dissolved in a small amount of methanol 
µ
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time (min) x volume (ml) x 
β-gal activity (Miller Units) =                          1000 x A420 
A660 
 
 
Extraction and Isolation  
 An outline of a typical isolation procedure is seen in Figure 6. Cells of P. 
fluorescens NCIB 10586, were pelleted by centrifugation (8,000 x g for 12 minutes). The 
acidified broth (pH ≈ 4.0) was then extracted with isobutyl methyl ketone (IBMK) and 
the organic extract was concentrated under reduced pressure. The dried extract (368 
mg/26 L) was run on a Sep-pak column and eluted from 20%-100% MeOH (10% 
3 2 4 ). Fraction 
of interest and was further purified using a Bakerbond C18 column 
 of 
d 
 
pletely purified using analytical HPLC with an elution system from 20-
r 30 minutes (UV monitoring at 214 nm and 254 nm). Peak three 
and four were found to correlate to an unknown metabolite (25) and indole-3-carboxylic 
gradient steps). Ten fractions were collected and tested for cell-signaling activity and also 
run on a TLC plate in CHCl :MeOH (9:1) (vanillin/H SO  spray; Appendix 1
four was found to be 
and elution from 40-60% aqueous MeOH in 5% increments, then 60%-100% MeOH in 
20% increments, followed by a final elution with one column volume of 100% MeOH. 
Fractions (1 mL) were collected and combined based on TLC analysis. The third group
fractions was further purified using an LH-20 column, 0.5 ml fractions were collecte
and combined based on TLC. The second group of LH-20 fractions (23 mg) purified by 
semi-preparative HPLC (Bakerbond C18) and isocratic elution with 53% aqueous ACN 
(UV monitoring at 214 nm and 254 nm). Six peaks were collected: peaks three, four, and
six were then com
90% aqueous ACN ove
 15
acid (2
ryptophol 
dole-3-aldehyde (23, 0.73 mg), indole-3-carboxylic acid (24, 1.2 mg), and 
an unknown m 25, 0.42 mg). UV spectra of these compounds were collected 
(Figure 7) and each compound was then tested for g e 
standard procedure (Table 1).  
H1, C13, DEPT, HMQC, COSY, and TOCSY NMR spectra were collected for 22 
and can be seen in Appendix 2-6. H1 NMR data was collected on 23, 24, and 25 (Figure 
8). Each compound was also run on the LC/MS from 20-90% aqueous acetonitrile/3 mM 
formic acid over 30 minutes (flow rate: 0.4 ml/min). Electrospray spectra in the positive 
and negative mode were collected. The specific mass spectrometer conditions can be 
found in Appendix 7. The mass spectra of 22, 23, 24, and 25 are shown in Appendix 8, 
Appendix 9, Appendix 10, and Appendix 11, respectively. GC/MS spectra were collected 
by running each of these isolates from 120°C-260°C at a temperature gradient of 20°C/14 
seconds. All this data was compiled to elucidate the structures of tryptophol (22), indole-
3-aldehyde (23), and indole-3-carboxylic acid (24). 
4), respectively. Peak six was found to contain two compounds, tryptophol (22) 
and indole-3-aldehyde (23). 
 This procedure was repeated three times (total 78 L of culture) to yield t
(22, 1.7 mg), in
etabolite (
cell-signaling activity followin th
 16
 
 
 
 
Figure 6:        Isolation of Tryptophol (22), indole-3-aldehyde (23), indole-3- 
                      carboxylic acid (24), and unknown metabolite (25) 
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Figure 7:        UV Spectra of Indole Derivatives 
   A)    indole-3-aldehyde (23) 
                B)    Tryptophol (22) 
 C)    indole-3-carboxylic acid (24) 
 D)    Unknown Metabolite (25) 
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able 1:        β-galactosidase Cell-Signaling Assay Results
Sample 
Name 
Mass 
(microgram) 
B-galactosidase Activity 
(Miller Units) 
  ample Control   S
indole-3-
aldehyde 24 528 336 
Tryptophol 25 841 336 
indole-3-
carboxylic 
acid 24 503 336 
Unknown 
Metabolite 32 407 405 
 
 
 
 
 
T
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        8     9 
              Tryptophol (22)                        R=CH2CH2OH 
               8’ 
 indole-3-aldehyde (23)             R=CHO 
                                   8’’ 
                              -3-carb acid 
 
 22 23 24 
 
       indole oxylic (24)    R=COOH 
     1H       13 1H            
 8.0 b
  7.1 s      12 7.1
7.4     11 8.4 d 8
7.2 t (7     12 7.4 t 7.3 t (4.5) 
7.2 t (8     11 7.5 t 7.5 t (4.6) 
Position             C 1H            
1 r s 8.7 br s 8.6 br s 
2            2.4  s 7.1 s 
4 d (7.3)      1.2 (3.2) .2 d (3.8) 
5 .5)       2.3 (3.9) 
6 .0)       9.5 (4.1) 
7 7.7 d (7.8)          118.9 7.9 d (2.9) 8.0 d (2.9) 
8 3.1 t (6.1)           28.8   
8’  10.1 s  
8’’   12.2 s 
9 4.0 t (6.2)           62.6   
OH  1.57 s   
 
 
 
 
 
Figure 8:          1H and 13C Data for 22, 23, and 24 
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PSEUDOMONAS RESULTS 
 
 
 Following extraction and fractionation of Pseudomonas fluorescens cultures 
several fractions were found to posses cell signaling activity. This large scale extraction 
eld  crude extract (1.1 g) which upon purification by various 
chromatography steps, four pure compounds were isolated. These pure compounds were 
entifi  as tr topho (22), indole-3-aldehyde (23), and indole-3-carboxylic acid (24)   
 ere fo nd to  activ in the ell-sig ay (Table 1). 
Characterization of Secondary Metabolites from Pseudomonas fluorescens 
 Compound 22, tryptophol was obtained as a white powder and displayed UV 
maxim nm and , which is consistent with an in y 
(Gilchrist ndonovsk rospray M wed an [M+ m/z 
162.2 con tent with t  C10H1 ptophol ents 
in the pos e ion ESI .1, 130 d 103. rved 
at variable cone voltages, and are consistent to fragmen  as shown in Figure 10. Of 
specific interest is the /z of 117.1, which corresponds to the parent 
dole group (C8H6N+) and the m/z of 144.1 indicating the loss of water. By GC/MS, 
veral corresponding peaks were present at m/z 161, 130, 117, and 103, further 
pporting the LC/MS data. Based on previously published H1 and C13 NMR spectra, the 
alues found here (Figure 11) are consistent with the proposed structure. The H1 NMR 
isplayed the presence of six aromatic protons consisting of δ 8.05 (1H, s, broad), 7.65 
1H, t, J=7.52 Hz), 7.16 (1H, t, J=7.29 
z), and 7.07 (1H, s), thereby indicating the presence of either a phenol or an aromatic  
of culture (78 L) yi ed
id ed yp l 
(Figure 9) and w u be e  c naling ass
a at 222  282 nm in acetonitrile dole moiet
, A i). The positive ion elect S sho H]+ at 
sis he molecular formula of 1NO for try  (22). Fragm
itiv MS at m/z values of 144 .1, 117.1, an 1 were obse
ts of 22
ESIMS+ fragment at m
in
se
su
v
d
(1H, d, J=7.76 Hz), 7.40 (1H, d, J=8.00 Hz), 7.24 (
H
 21
 
 
C:    Compound 24, indole-3-carboxylic acid 
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Figure 9:        Structures of Pseudomonas fluorescens Isolates 
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Figure 10:  entation of Compound 22, Tryptophol 
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Position 
H1 Chemical 
Shift J (Hz) 
C13 Chemical 
Shift 
H1 
Multiplicity 
H1 
Integration 
1 8.05     s 1 
2 7.07   122.43 s 1 
4 7.40 7.29 111.19 d 1 
5 7.24 7.52 122.25 t 1 
6 7.16 8.00 119.52 t 1 
7 7.65 7.76 118.86 d 1 
8 3.08 6.07 28.78 t 2 
9 3.95 6.16 62.64 t 2 
OH 1.57     s 1 
 
 
 
 
 
 
 
 
Figure 11:        Compiled NMR (CDCl3) Data for Compound 22, Tryptophol 
 24
amine group due to the broad singlet and the presence of a two ring system due to the 
litting pattern. Further H1 NMR data included the presence of protons at δ 3.95 (2H, t, 
6.16 Hz) and 3.08 (2H, t, J=6.07 Hz), indicating the presence an alkyl chain. TOCSY 
NMR revealed three spin systems to be present, where the protons at δ 8.05 and 7.07 
composed spin system one, protons at δ 7.65, 7.40, 7.24, and 7.16 composed spin system 
two, and protons at δ 3.95 and 3.08 composed the final spin system.  HMQC correlations 
 conjunction with DEPT NMR data revealed that the protons at δ 3.95 and 3.08 are 
ttached to carbons at δ 62.64 (CH2) and 28.78 (CH2), respectively, and the HMQC NMR 
ata was established that the protons at δ 8.05 and 1.57 are not attached to carbons, 
dicating the possibility of attachment to either oxygen or nitrogen. COSY correlations 
showed the following couplings δ 7.16/δ 7.65. Further couplings exist between δ 7.2
7.40 and δ 7.24/δ 7.16. Based on all the structural data collected, com 22 was 
ident d as trypto
 Compound ole-3-a e, was o s a white pow er, but the 
amount of material isolated was not enough to carry out a complete spectral analysis. 
However the identification of the cl ely related co ryptopho 22) allowed a
orrelation between the two compounds to be established. The UV spectrum of 23 in 
queous acetonitrile had UV maxima at 244 nm, 259 nm, and 298 nm. When these UV 
axima are compared to those for a typical indole the values are slightly higher than 
xpected, 244 nm and 298 nm. This would indicate extended conjugation within the 
of a third 
UV maximum, 259 nm, revealed the presence of a carbonyl group, which is typically  
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system causing the maxima to shift to longer wavelengths. Also, the presence 
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found around 270 nm caused by the n-π* transition (Crews, 1998). In the positive ion 
ESIMS, a peak corresponding to [M+H]+ was observed at m/z 146.1 consistent with a 
molecular formula of C9H7NO. Fragments in the positive ion ESIMS showed [M+H]+ 
peaks at m/z values of 117.1 (C8H6N+) and 103.1 (C6H5N+) at variable cone voltages. 
Both of these fragments were also present in the tryptophol (22) and correspond to 
fragmentation of the base indole structure.  The H  NMR (Figure 12) displayed the 
presence of six aromatic protons just as was found in 22, consisting of δ 8.70 (1H, s, 
broad), 8.35 (1H, d, J= 3.15), 7.88 (1H, d, J=2.90), 7.47 (1H, t, J= 4.06), 7.36 (1H, t, J= 
3.93), 7.07 (1H, s). This pattern of aromatic splitting was almost identical with that f
1
or 22 
further supporting the close structural similarity between the two molecules. Significantly 
the H1 NMR data revealed a proton resonance at δ10.12 consistent with the presence of 
an aldehyde group. Despite the lack of further NMR data due to the lack of material, 
compound 23 was identified as indole-3-aldehyde. 
 Compound 24, indole-3-carboxylic acid, was also obtained as a white powder. 
Once again the small amounts of compound isolated (0.68 mg) precluded full structural 
analysis, but again based on the tryptophol spectral information the structure of the 
closely related compound 24 could be deduced. The UV spectrum of indole-3-carboxylic 
acid (24) in aqueous acetonitrile/0.1% TFA had UV maxima at 210 nm, 228 nm and 285 
nm, where the later two maxima are within the typical range for an indole group. The 
presence of a UV maximum at 210 nm is indicative of a carboxylic acid carbonyl group, 
which is typically around 200 nm (Crews, 1998). In positive ion ESIMS, a peak 
corresponding to [M+H]+ was observed at m/z 162.2. Fragment peaks present in the  
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Figure 12:        H  NMR (CDCl3) Data for Compound 23, indole-3-aldehyde 
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positive ion ESIMS corresponding to [M+H]+ were observed at m/z 144.1, 117.1, and 
03.1, consistent with an indole structure. The H1 NMR (Figure 13) showed the presence 
f six aromatic protons at δ 8.63 (1H, s, broad), 8.24 (1H, d, J=3.80), 8.02 (1H, d, 
J=2.90), 7.47 (1H, t, J=4.56), 7.33 (1H, t, J=4.53) and 7.07 (1H, s), once again almost 
identical with the pattern obtained for compound 22. The H1 NMR data also contained 
exchangeable singlet at δ 12.16, indicating the presence of a carboxylic acid group. While 
this data alone was not enough to finalize the structure, but the data strongly suggests that 
ompound 24 is indole-3-carboxylic acid. Also, this was confirmed by comparison with a 
nown standard. 
An unknown metabolite (25) was obtained as a yellow-white powder. The UV 
ectrum of 25 in aqueous acetonitrile had UV maxima at 247 nm and 334 nm. In 
positive ion ES   a ]+  a 
possible molecular formula of C . Fragme s in positi ion ESIMS esponding 
to [M+H]+ peaks w  present at 20,106 , indic g the loss o ter 
followed by the loss of a  –CH2 group. The last fragment, m/z 3.1, could be accounted 
for by the loss of a onia and of water. n importa
e lack of a mass fragment at m/z 117.1 characteristic of an indole moiety GC/MS data 
ollected showed mass fragments at 137, 119, and 92; confirming the molecular weight 
f the compound, but did not provide any further structural data. The H1 NMR displayed 
the presence of four aromatic protons at δ 7.90 (1H, d, J=8.47), 7.33 (1H, s), 7.25 (1H, s), 
and 6.69 (1H, d, J=7.59) as well as two low field protons at δ 1.46 (1H, s) and 1.28 (3H, 
s). The NMR data was not consistent with an indole ring system and could not be  
1
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Figure 13:        H  NMR (CDCl3) Data for Compound 24, indole-3-carboxylic acid 
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correlated with the mass spectral data that was collected, leading to the inability to 
educe the structure of compound 25. 
Cell-Signaling Activity of Pseudomonas fluorescens Isolates 
 Pseudomonas fluorescens has been shown to produce several autoinducers, a few 
of which are also common in Pseudomonas aeruginosa strains (El-Sayed, 2001). 
Interestingly, none of these commonly found autoinducers were detected in the LC/MS 
nalysis of the culture extract fractions, but based on the β-galactosidase assay carried out 
t Eastern Carolina University School of Medicine several culture extract fractions 
owed activity. Upon isolation, 22, 23, and 24 were shown to have cell-signaling 
ctivity, where the activity is based on the relative absorbance of ONP due to the 
production of β a a n  
compounds, tryptophol (22) had nearly twice the cell-signali ctivity, 841 Miller units, 
as indole-3-aldehyde (23)(528 M nits) an e-3-carb ylic acid (2 03 Miller 
units). The control was 336 Miller units. Based on the moles of compound that was 
tested, molar activity was found to be 5.43 x 109 tivity/mol, 3.18 x 109acti /mol, and 
.38 x 109 activity/mol for 22, 23, and 24, respectively. Comparing these activities based 
n their molar values, tryptophol (22) is 41% more active than indole-3-aldehyde (23) 
nd 38% more active than indole-3-carboxylic acid (24).    
ioactivity of Pseudomonas fluorescens Isolates 
In previous studies, tryptophol has been found to act as an antifungal agent 
ed out 
n the antibacterial activity of this molecule or the other compounds isolated within this 
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against Mortierella ramannianus (Li, 1994), but no reported studies have been carri
o
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study. From the bioassay none of the isolated compounds were found to have any 
bioactivity. 
Pseudomonic Acid A (1) Detection 
 Surprisingly, pseudomonic acid A was not found in any of the cultures of P. 
fluorescens although numerous growths were tried. The search for 1 was performe
TLC comparisons with a standard sample, but this posed problems since there were man
compounds that had a similar Rf value (0.24-0.30) and had the same purple-gray color 
when sprayed with vanillin. Further analysis was carried out after the first purificatio
step, and each group of fractions was tested using a standard HPLC/UV procedure 
developed using the pseudomonic acid A (1) standard and retention times were 
compared. Based on these tests, several fractions could have contained pseudomonic 
A (1) peak present, but absolute confirmation was not possible due to the complexity of 
the samples. Finally, LC/MS was employed to various fractions. From three growths, 
using a procedure developed for the pseudomonic acid A (1) standard. Once again, 
pseudomonic acid A (1) could not be detected in any sample. 
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PSEUDOMONAS DISCUSSION 
 
 Three indole derivatives were isolated from Pseudomonas fluorescens broth 
cultures and were found to exhibit cell-signaling activity. Following structural 
characterization, these derivatives were identified as tryptophol (22), indole-3-aldehyde 
(23), and indole-3-carboxylic acid (24). Each of these compounds has previously been 
isolated from a diverse group of organisms, although none have been associated with cell 
signaling in bacteria.  
 The most active cell-signaling compound was found to be tryptophol (22), a 
known antifungal and auxin agent, previously isolated from Aspergillus niger, Balansia 
epichloe, Ircinia spinulosa, Pseudomonas fluorescens (strain KGPP 937), and Rhizobium 
sp (Ten, 2000; Lebuhn, 1997). These sources included plant-associated bacteria, a marine 
sponge, and fungi. The specific means of auxin action of tryptophol (TOL) (22) results 
from its uptake by plants and the conversion to the active phytohormone, indole-3-acetic 
acid (IAA) (31), by plant TOL-oxidase and oxygen. While IAA is the active auxin 
present in most bacterial cultures, auxin production shifts to 22 in an O2- deficient system, 
possibly due to an increased microbial activity in soil microhabitats (Lebuhn, 1997). 
These attributes coincide with the data collected within this study; the ability of 
tryptophol (22) to act a cell-signaling molecule indicates its role as an auxin-like 
compound. Whether tryptophol (22) acts as a cell-signal for the producing bacteria or for 
the plants is unknown, but based on the fact that tryptophol (22) has been found to act as 
an auxin it is believed that tryptophol causes a cell-signaling cascade within the plant cell 
system. The possible use of tryptophol (22) as a precursor for 31 leads to many 
possibilities for enhanced crop growth. A further advantage to the supplementation of 
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plants with tryptophol (22) he greater rate of uptake 
of tryptophol (22) by the plant cell (Lebuhn, 1997).  
The other two less active compounds, indole-3-aldehyde (23) and indole-3-
carboxylic acid (24) were found to have virtually identical cell-signaling activity. To 
date, neither of these compounds has been found in plant-associated bacteria and only 
minimal information has been recorded about their ability to act as auxin-like compounds 
or to exhibit any other forms of bioactivity. Previous isolation of 23 has been found from 
a red alga Chondira sp. and also a Halichondria sp., a marine sponge. While 24 has been 
isolated from fungi, Aporpium caryae. While produced by different organisms, the 
structural similarity of these compounds provide an interesting opportunity to explore a 
structure-activity study. While the indole moiety appears in all of the elucidated 
structures, the side chain of each is variable. A variation in side chain length also affects 
the signaling activity of the AHL quorum sensing compounds.  In the case of the indole 
derivatives it appears that a smaller side chain results in decreased activity, possibly as a 
result of decreased affinity for the luxR type receptor, therefore decreasing the induction 
level, but not losing it entirely. While less active than tryptophol, these compounds may 
allow the possible application as bacterial control agents. Since tryptophol (22) has been 
found to lyse human red blood cells and induce a sleep-like state, these derivatives may 
have reduced negative side effects (Seed, 1978). If these side effects can be eliminated, 
the use of 23 and 24 as therapeutic agents holds great merit. Consequentially, it would be 
interesting to perform toxicology studies to access their potential as medicinal agents.  
The unknown metabolite, compound 25 did not demonstrate cell-signaling 
activity. The NMR and MS data are conflicting, and the molecular data is not consistent 
rather than the direct use of IAA is t
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with an indole structure, in line with the idea that the indole moiety is necessary for cell 
signaling activity. 
As was noted earlier, the production of pseudomonic acid by Pseudomonas 
fluorescens has been found to be regulated by a quorum sensing system (El-Sayed, 20
Along with these findings, it is also known that when pseudomonic acid is produced, tw
common AHLs (C10HSL (29) and C6HSL (30)) are present in organic extracts (El-
Sayed, 2001). While within this study neither 29 or 30 were detected by LC/MS, which 
could account for the absence of pseudomonic acid in these cultures. This hypothesis 
could be examined by the addition of these AHLs to the growth media with the aim of 
activating pseudomonic acid (1) production. 
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 Within this study, four secondary metabolites from Pseudomonas fluorescens 
were isolated and three of these were identified: tryptophol (indole-3-ethanol) (22), 
indole-  not 
ll-
ell-signaling activity. 
Finally, while the new quorum sensing compounds were found in cultures of 
Pseudomonas fluorescens, the common signaling compounds required in the production 
of pseudomonic acid (1) were not present. This could explain the absence of this 
compound in culture of P. fluorescens that were examined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3-aldehyde (23), indole-3-carboxylic acid (24).  The fourth metabolites could
be characterized based on current data. Each of the characterized indole derivatives was 
found to posses cell-signaling activity based on the standard  β-galactosidase assay, while 
the unknown metabolite was inactive. Based on the results found here, the lack of ce
signaling activity of the unknown metabolite may be due to the incomplete formation of 
the indole ring system, but full structure elucidation is still needed.  
 There may be biotechnological or therapeutic potential for these compounds of 
their derivatives due to their ability to affect c
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MICROCYSTIN INTRODUCTION 
  
According to a variety of health studies, the average person should consume eight 
cups of water a day, which translates into 182 gallons of water per year. For this reason it
is necessary to have a set of drinking water standards to ensure the safety of drinking 
water supplies. In 1974, the Safe Drinking Water Act (SDWA, 2003) was established in
order to “protect public health from [water] source to tap” (EPA, 2003). The overall 
purpose of the SDWA was to set national health-based standards for 
 
 
drinking water to 
t 
 have been made. 
 of 
mum 
 (HAB, 2002). As of 1994, 
ll of these countries have now set the maximum acceptable level to 0.1µg/L of 
icrocystins in drinking water (Rivasseau, 1998). From the lead of these countries and 
urrent toxicity studies, it has been established that there is a health risk at hand and 
ction needs to be taken to monitor the consumption of these toxins. 
Cyanobacteria or blue-green algae are photosynthetic bacteria that grow in both 
utrophic freshwater and brackish water environments (Ohtake, 1989). These eubacteria 
re unicellular and can form massive colonies called blooms. Although structurally 
lated to bacteria, blue-green algae have the ability to photosynthesize, and contain 
hlorophyll A and accessory pigments such as phycocyanin, which results in their blue-
protect against both naturally occurring and man-made contaminants that may be presen
(EPA, 2003). Upon the enactment of the SDWA, many amendments
One that has not yet been added is the establishment of maximum consumption levels
several caustic natural water toxins, such as the microcystins produced by cyanobacteria. 
Currently only Australia, Canada, and Great Britain have moved to establish maxi
acceptable levels for microcystins in drinking water supplies
a
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green coloration. These o nd produce a range of 
bolites including toxins. 
 
 
itors 
aeruginosins (34), a 
linear i, 
rganisms thrive in eutrophic conditions a
secondary meta
Although not all cyanobacteria cause threats to the environment, approximately 
50-70% are found to be toxic (Fogg, 1998). At least 19 species belonging to nine genera 
have been shown to be toxin producers, and among these one of the major toxin 
producers is the Microcystis genera (HAB, 2002). Geographically, Microcystis 
aeruginosa is the most widely distributed among the toxic cyanobacteria, and 
consequently much emphasis has been placed on the study of this organism. M. 
aeruginosa grows in colonies, as do many other species, forming spherical, ellipsoidal, or 
irregularly lobed blooms. These colonies can be up to several centimeters in diameter 
where the individual cells are spherical and about 4.5 µm in diameter (HAB, 2002).  
 A number of toxins have been isolated from M. aeruginosa. These include the 
microcystins, microginins (32), micropeptins (33), and aeruginosins (34)(Figure 14). The
microginins (32) are linear peptides that act as amino-protease inhibitors, including 
leucine aminopeptidase, aminopeptidase M, and angiotensin-converting enzyme 
inhibitors (Ishida, 2000; Reshef, 2001). The micropeptins (33) contain a cyclic 
depsipeptide and have been found to act as a serine protease inhibitor as well as inhib
of plasmin and thrombin (Ishida, 1995; Reshef, 2001). Lastly are the 
peptide, commonly found to inhibit trypsin and thrombin (Ishida, 1999; Murakam
1995) and also show cytotoxicity against P388 murine leukemia cells (Ishida, 2002).  
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C:    Aeruginosin 98-B (34) 
 
Figure 14:         Examples of Toxins from Microcystis aeruginosa 
              A)    Micropeptin SD944 (33) 
              B)    Microginin 478 (32) 
              C)    Aeruginosin 98-B (34) 
A:     Micropeptin SD944 (33) 
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 Of all the M. aeruginosa metabolites that are known, it is the microcystins that are 
the greatest threat to public health. Microcystins are also produced by other species of 
cyanobacteria, including Microcystis viridis, Nostoc sp., Oscillatoria agardhii, and 
Anabaena flos-aquae (Harada, 1988).  However, of all the toxin producing species, the 
most predominant producer of microcystins is M. aeruginosa.  From these particular 
species over 60 microcystin derivatives have been found to make up the group of 
microcystins.  Among these, Microcystin LR (35) is the most abundant and has been 
found to have the greatest toxicity (Hyenstrand, 2001; Lawton, 2001). 
These microcystin derivatives are cyclic heptapeptides containing a seven-
membered peptide ring, composed of five non-protein amino acids and two protein amino 
acids. As seen in Figure 15, these heptapeptides are composed of γ-linked D-glutamic 
acid (D-Glu), D-alanine (D-Ala), β-linked D-erythro-β-methylaspartic acid (D-MeAsp), 
N-methyldehydroalanine (Mdha), a unique C20 β-amino acid (Adda), and two variable L-
amino acids. In most cases, variability in the structure is only seen at the protein amino 
acid positions, although other variations can occur (Matthiensen, 2000). Such variability 
leads to changes in the hydrophobicity and acidity of the specific compound. Those 
microcystins, which have tryptophan or phenylalanine as one of the variable amino acids, 
are generally more non-polar than those without (Lawton, 1995). Some specific examples 
of the variable amino acids can be found in Figures 15.  
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Figure 15:       General Structure of Microcystins; Variable protein L-amino acids at    
                        position X and Z 
X Z
Microcystin LR Leu Arg
Microcystin RR Arg Arg
Microcystin YR Try Arg
Microcystin LF Leu Phe
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  Microcystins are hepatotoxins that target the liver and show many destructive 
physiological effects, including distortion of the liver architecture, rearrangement of 
cellular organelles, and internal bleeding of the liver. (Codd, 1995; Falconer, 1988; 
McDermott, 1995). All of these physiological effects occur due to specific biochemical 
reactions that take place.  Specifically, these toxins have been found to inhibit the 
serine/threonine protein phosphatases PP1 and PP2A (Bell, 2001). These protein 
phosphatases are crucial enzymes in tumor suppression and when inactivated by 
microcystins can cause the development of tumors (Lawton, 1995).  
Human exposure to microcystins has been reported in several instances. Th
serious occurrence took place in Caruaru, Brazil in 1996. When 60 patients died of acute 
liver failure after having undergone dialysis where microcystin contaminated the water
that was used (Hummert, 1999).  In addition to humans, microcystins have also caused 
the death of many farm animals (Hummert, 1999).  
 A number of methods for the detection of microcystins have been reported 
(Lawton, 2001). These include chemical detection based on LC/UV and biochemical 
methods using protein phosphatase assay or ELISA (enzyme-linked immunosorbant 
assay). All of these methods leave room for improvement based on their cross-reactivity 
and inability to quantify the amount of toxins present or provide an accurate profile of the 
toxins present. For instance, the ELISA test is based on t
e most 
 
he molecular recognition by 
ertain antibodies, and the antibody will have different specificity towards each 
icrocystin variant (Lawrence, 2001; Bouaicha, 1996). This causes the assay to 
accurately detect total microcystin content and leads to the possibility of false positives 
arada, 1988). The protein phosphatase assay functions as a measure of phosphatase 
c
m
in
(H
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inhibition, but the assay may detect not only microcystins, but also unrelated compounds 
such as okadaic acid (another phosphatase inhibitor) and does not allow the 
differentiation between the microcystin variants (Harada, 1988; Lawrence, 2001). Of the 
methods under investigation, LC/UV has good potential for providing data on the toxin 
profile, but the method lacks sensitivity. As was previously mentioned, the current 
maximum allowable level of microcystins in drinking water is 0.1µg/L. For this reason, a 
highly sensitive method must be developed to monitor and quantify these toxins. The 
of the thesis was to investigate and develop a new analytical 
ethod, based on LC/MS techniques for the detection of microcystins. 
purpose of this section 
m
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MICROCYSTIN EXPERIMENTAL 
 
 
General 
 Sample concentration was carried out using 10 g/ 60 ml ENVI-18 Sep-pak 
columns (Supelco). HPLC/MS was performed using a Hewlett Packard 1100 coupled 
with a Waters Micromass mass spectrometer using a TSK-GEL Amide 80 column (2.0 x 
100 mm) (Tosoh Biosep) or a Agilent Eclipse C18 (2.0 x125 mm) column. Filtration was 
carried out using Whatman GF/A disks (30 cm diameter). Samples were sonicated using 
a Fisher Scientific FS60. All solvents were HPLC grade (Fisher). Concentration under 
reduced pressure was carried out using a Buchi rotoevaporator model R3000. 
 
 
12), 1 ml biotin stock solution 
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Microcystis aeruginosa Culture 
 All cultures were grown by Eve Wright using the following procedure. In a 1 L 
volumetric flask, 1 ml B12 stock solution (Appendix 
(Appendix 12), and 200 mg of thiamine HCl were combined. DI water was then add
under analytical procedures. In a separate 1 L volumetric flask, 1 ml trace metal stock 
solution (Appendix 12), 3.15 g FeCl3•6H2O, and 4.36 g Na2EDTA•2H2O were 
combined. DI water was added under analytical procedures. Milli-Q water and the growth
media solutions (total volume 1.5L) were added to each Fernbach flask. Flasks were 
autoclaved and allowed to cool for 24 hours, before inoculation with approximately 10
ml stock Microcystis aeruginosa cultures (100 mL). Cultures were incubated at r
temperature for three weeks with daily agitation. 
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Extraction and Purification 
 Following growth, cultures were filtered and collected cells were stor
freezer at -20°C for at least 24 hours.  The filtrate was collected in 4 L amber glass 
bottles and stored at room temperature for further experimentation. 
 The cells collected on filter paper disks were extracted with 75% aqueous 
methanol (250 ml) sonicated, and left for an hour. The organic layer was decanted and 
the process was repeated two more times. The extracts were concentrated under reduce
pressure. 
In separate experiments the cells were extracted using 75% aque
 
ed in a 
d 
ous 
methanol/0.1% TFA as the extraction solvent. As a further comparison, another disk was 
extracted with 100% methanol/0.1% TFA. Each type of solvent extraction was carried 
out in triplicate and dried extracts were stored at -20°C for further experimentation. The 
organic material obtained in each extract was weighed and compared (Table 2). 
Each crude extract was dissolved in 100% methanol (20 ml) and was filtered to 
remove any cell debris. The filtrate was concentrated under reduced pressure. This 
organic extract was fractionated using a Sep-pak cartridge activated with 3 column 
volumes of 100% methanol, then eluted with 3 column volumes of 20% aqueous 
methanol. The extract was taken up in 20% aqueous methanol (2 ml), briefly sonicated, 
and applied to the Sep-pak cartridge. The column was eluted with one column volume of 
each of the following solvent mixtures: 20%, 40%, 60%, 80%, and 100% methanol and, 
finally 100% hexane. Each gradient step and wash was collected separately and was 
concentrated under reduced pressure. The weight of each fraction was recorded. 
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Trial 1 Trial 2 Trial 3
ct 2 extract 3
 mg 0.6 mg
75% MeOH/0.1% TFA 23.9 mg 14.1 mg 0.9 mg 24.3 mg 12.6 mg 0.8 mg 29.2 mg 14.7 mg 0.5 mg
00% MeOH/0.1% TFA 44 mg 7.2 mg 0.3 mg 38.5 mg 8.8 mg 0.2 mg 40.8 mg 7.6 mg 0.3 mg
extract 1 extract 2 extract 3 extract 1 extract 2 extract 3 extract 1 extra
75% MeOH 24.6 mg 13.4 mg 0.2 mg 27.9 mg 14.2 mg 1.4 mg 25.9 mg 13.3
 
1
 
Table 2: Comparison of Extraction Methods Based on Biomass Determination
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       The supernatant from filtered growth media was used as the source of “natural 
 100% methanol, 
 water” 
Each fraction was collected separately, concentrated under reduced pressure, 
and sto carried out 
, LC 
conditi
e 
e UV 
 
 the 
natural water fractions were 40 µl and 200 µl, respectively. Each fraction was run  
water” samples. This was used in the method development for analysis of raw water 
samples obtained from North Carolina lakes and reservoirs. 
       A Sep-pak cartridge was activated with 3 column volumes of
followed by the equilibration with 3 column volumes of 100% water. The “natural
sample was passed through the Sep-pak cartridge at a flow rate of approximately 20 
ml/min (1.5 L water/10g Sep-pak). Then the column was eluted with 20% and 100% 
methanol. 
red at -20°C (the weights of each were recorded) This procedure was 
three times in entirety to determine reproducibility. 
HPLC/UV Method Development 
Various methods were carried out using four microcystin research samples 
(MCLR (35), MCRR (37), MCYR (36), MCLF (38)). Following experimentation
ons used for all subsequent experiments are listed in Appendix 12. The traces 
shown in Figure 16 represent the HPLC chromatograms obtained from the use of th
standard HILIC and reversed phase column methods. From these chromatograms, th
spectra of the microcystins were obtained (Appendix 13).  
Detection of Microcystins Using LC/MS 
 Both the extracted cell fractions and the natural water fractions were processed in 
the same manner. Dried fractions were re-dissolved in 50% aqueous acetonitrile (1 ml). 
For detection purposes, each fraction was run in duplicate using the HILIC conditions
described in Appendix 12. The injection volumes for the cell extract fractions and
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A. Standard Trace of Microcystin Standards on Reversed Phase Column 
 
 
B. Standard Trace of Microcystin Standards on HILIC Column 
 
 
 
Figure 16:          HPLC/UV Traces of Microcystin standards  
A)   Standard Trace of Microcystin Standard on Reversed Phase    
        Column 
B)   Standard Trace of Microcystin Standards on HILIC Column 
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rmined based on their 
ret
 
 
 was recorded. Four samples of the 
50 µg), were prepared as above. Each microcystin 
standar o 
 
e 
ly developed for the Amide 80 column and the 
ough the HPLC system and the compounds were monitored with both a diode array 
detector (DAD) and a mass spectrometer (MS). The conditions of the mass spectrometer 
can be found in Appendix A. Microcystin presence was dete
ention time, UV maximum, and [M + H]+ values. Mass spectra of the microcystin 
standards can be seen in Appendix 14. A comparison between effectiveness of the 
various extraction techniques was carried out using these HPLC/UV/MS methods. A
comparison of these methods can be found in Table 3. 
Preparation of Quantification Standards 
An aliquot (ca. 50 µg) of each microcystin standard was weighed out using a 
Cahn 28 Electrobalance, and the final weight of each
internal standard, actinomycin D (
d was placed into a separate vial and an actinomycin D samples was added t
each. Methanol (200 µl) was added and the vial sonicated. Each disk was then removed
and washed with MeOH (100 µl) into the corresponding vial, and the MeOH removed in 
vacuo. Serial dilutions of each of the four microcystin standards were carried out in th
same manner. The final concentrations for each dilution can be found in Table 4.  
Quantification 
 Using the LC/MS method previous
QuanLynx program, calibration curves were created. Quantification parameters for each 
of the microcystin standards were based on peak area as compared to the internal 
standard, actinomycin. Each standard peak was selected based on retention time ± 0. 2 
minutes, and based on these, calibration curves were produced using a linear polynomial,  
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A: Extraction with 75% aqueous MeOH/0.1% TFA 
 
B: Extraction with 75% aqueous MeOH  
 
 
 
 
 
able 3:  Comparison of Extractions With and Without TFA through Mass 
Spectrometer and Ultraviolet Detection of MCLR 
A) Extraction with 75% aqueous MeOH/0.1% TFA 
B) Extraction with 75% aqueous MeOH 
 
            MCLR Presence
MeOH Elution MS Detection UV Detection
20% N N
40% N N
60% Y Y
100% N N
Hexane N N
80% N N
           MCLR Presence
MeOH Elution MS Detection UV Detection
20% N N
40% N N
60% Y N
80% N N
100% N N
Hexane N N
T
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Stan
Concentration Concentration Concentration 
 
Concentration 
dard Stock Solution Dilution 1 Dilution 2 Dilution 3
MCLR 102.5 µg/ml 25.6 µg/ml 6.4 µg/ml 1.6 µg/ml 
MCYR 360.0 µg/ml 120.0 µg/ml 40.0 µg/ml 13.0 µg/m
 
 
 
 
 
MCRR 117.5 µg/ml 29.5 µg/ml 7.8 µg/ml 1.9 µg/ml 
l 
MCLF 55.0 µg/ml 27.5 µg/ml 13.8 µg/ml 6.9 µg/ml 
 
 
Table 4:          Quantification Standard Concentrations for Each Microcystin Standard
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excluding the point of origin, and fit weighting the line to 1/X. For each of the 
icrocystin standards, the four serial dilutions were run in sequence and their MS 
sponse was monitored and incorporated into the QuanLynx program for analysis. Based 
on the pre-programmed conditions just mentioned, the response of each of the dilutions 
was plotted versus the concentration (µg/ml), Figure 17. Each standard was run in 
duplicate. Each duplicate calibration curve was averaged to give the final curves for each 
type of calibration. 
 Following the development of MS calibration curves, UV calibration curves were 
produced. The same MCLR (35) serial dilution standards were used and the UV peak 
area response was monitored. The injected amount (µg) was then plotted versus the UV 
response (Figure 18). 
m
re
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Figure 17:       Standard Calibration Curves of Three Microcy
 
 
 
 
 
A.        Mass Spectrometer Response vs. Concentration
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R2 = 0.9994
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 MICROCYSTIN RESULTS 
fficiency of Solvent Extractions 
Three different solvent extraction methods were compared to determine the most 
fficient for recovery of microcystins with the least dissolved organic matter. Two 
xtraction solvents were considered: 100% methanol and 75% aqueous methanol. The 
pure organic extraction was found to extract approximately 17 % more total biomass on 
average. However, TLC comparisons of the two extracts indicated considerably more 
chlorophyll was present in the organic extract. After comparing these results, the aqueous 
organic solvent was selected to reduce the interference of the chlorophyll. 
 Further improvement in microcystin extraction was achieved by adding 0.1% 
TFA (trifluoroa ). This was determined by LC/MS analysis of the fractions 
obtained following separation on a Sep-pak cartridge. Each fraction was injected in the 
same concentration and was run in duplicate to ensure accurate detection (Table 3). 
Based on these results it can be deduced that the 75% aqueous methanol/0.1% TFA 
extract had a greater amount of MCLR (35) present, due to the detection of MCLR (35) 
by UV (a less sensitive measuring technique) in the TFA extract. 
Optimum extraction repetition for complete toxin extraction was determined for 
it was found that two extractions were sufficient, since only 1% additional biomass was 
obtained in the third extraction, regardless of the solvent used. From these experiments 
the optimum procedure was determined to be a double extraction of the cells using 75% 
aqueous MeOH/0.1% TFA. 
 
 
E
 
 
e
e
cetic acid
e l traction and compared (Table 2). Once again based on theach so vent ex se experiments 
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Efficiency of Extract Fractionation 
The efficiency of the initial Sep-pak clean-up step of the crude extract was tested 
sing LC/MS analysis. The crude extract was eluted with: 20%, 40%, 60%, 80%, 100%: 
ethanol and 100% hexane, and each fraction was monitored by LC/MS. MCLR (35) 
was only found in the 60% aqueous methanol fraction (Table 3). 
Further experimentation of the clean-up step for raw water samples was carried 
out by passing the raw water samples through a 10g/60ml Sep-pak cartridge. After 
passing 1.5 L of water through the column, material began to diffuse slightly down the 
column. Based on this, the column was changed every 1.5 L to ensure that the organics 
were retained on the column. The column was then washed with 20% aqueous methanol 
followed by elution with 100% methanol. The aqueous organic fraction contained about 
26% of unwanted material (by weight), with no microcystins present by LC/MS analysis. 
In contrast the organic fraction contained both MCLR (35) and MCRR (37). 
HPLC Method Development 
Two different chromatography systems were examined: the reversed phase 
ethod using a C18 column, and another based on hydrophilic liquid interaction 
chromatography (HILIC). Of most importance was baseline separation of the 
microcystins to permit accurate quantification of microcystins present in collected 
fractions. Other features such a run duration, sharpness of peaks, and absence of 
compounds in the solvent front were also important considerations.  
Reversed phase chromatography was performed using an Agilent Eclipse C18 
column, and while a few of the methods allowed some separation, only one method 
showed complete resolution and sharpness of peaks (Figure 16). 
u
m
m
 55
In an alternate approach (HILIC) an Amide 80 column was used, which is 
pically used for peptides such as the microcystins. Although all microcystins were 
 more complex procedure was required to clean the 
olumn
 
d 
ocystins, such 
as MCL
s 
 
 
 
ty
resolved using a simple gradient, a
c . Specifically this method allowed baseline separation of MCLR (35) and MCYR 
(36), which was not found in previously developed methods. Another feature of this
HILIC approach was the juxtaposition of two different separation methods, namely 
reversed phase and HILIC, to reduce the effect of interfering peaks in the final LC/MS 
analysis step. This was indeed found to be the case and the HILIC method had the adde
advantage of good separation over a slightly shorter run time. The only drawback to the 
use of the Amide 80 column is the rapid elution of the more non-polar micr
F (38). 
Comparison between LC/UV and LC/MS Detection 
In some cases UV detection can be seen as a qualitative feature, since the 
absorbance of a compound is mainly based on the functionality of the molecule and i
dependent on the wavelength the absorbance is monitored at, while MS detection is a
quantitative measure. This is due to the fact that peak height/area is directly related to the
amount of compound present. 
Due to this, from this analysis the limit of detection (LOD) for UV detection was 
found to be 3.6 µg/L, while for MS detection the LOD was 0.08 µg/L, based on initial 
sample concentration. These values are very important when determining the most 
efficient method to monitor drinking water supplies. Due to current standards in drinking
water, 0.1 µg/L, UV detection would not be able to detect these low concentrations of 
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toxins. For this reason MS detection is more reliable method for monitoring microcystin 
levels. 
as available was not 
sufficie
en 
imits of 
e was compared to UV detection. The same MCLR 
dilution ion. 
s a 
 case of the 
e 
.79. This 
pound is present. In 
other w s 
Calibration Curves 
 With the exception of MCLF (38), calibration curves were attainable for the 
microcystin standards. The amount of MCLF (38) standard that w
nt to acquire accurate readings with either UV or MS detection. The most 
concentrated 38 sample (55µg/ml) caused a small MS response, but upon making ev
slight dilutions (27.5µg/ml) the detection by MS was no longer possible. While MCLF 
(38) did not give accurate readings, the other three microcystin standards gave good 
readings. These three standards were run in duplicate to ensure repeatability. From the 
testing, the calibration curves were within acceptable limits of error based on their R 
values and consistency between duplicate curves was present. From the MS calibration 
curves it was determined that there was a linear response and was within the l
error. The MS calibration curv
s were used and produced a linear curve comparable to that from MS detect
Both MS and UV calibration curves for 35 are linear, but the UV curve ha
slightly higher R value. Of further comparison is the positive y-intercept in the
UV calibration curve, likely due to background absorbance. Another difference is th
increased slope of the UV calibration curve, 159.32, while the MS slope was 105
could possibly be due to amplification of absorbance when more com
ords as more of the same compound is present the ability of excitation become
increasingly easier, resulting in amplification of absorbance.  
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MICROCYSTIN DISCUSSION 
 
 As the frequency of blue-green algal blooms in drinking water supplies become
more frequent, the need to efficiently and accurately measure the presence of algal toxins 
in the waters is rising. While the presence of blue-green algae toxins are known, they
considered unregulated known contaminants, according to the Environmental Protec
Agency. At this point, the problem has been established, but specific monitoring 
techniques and regulations have not been enacted. Currently in the United States there are
no regulations to address this problem, but recently, steps have been taken by the North 
Carolina Department of Health to monitor the presence of these toxins, specifically 
microcystins.  
s 
 are 
tion 
 
h blue green algal toxins, there is a 
need fo
ial 
al methods such as LC/UV have been explored but the 
drawba
 
ve 
allowable levels has been successfully applied to laboratory and North Carolina drinking 
 Due to the possible health risks associated wit
r an accurate detection and quantification of these toxins. To date, various 
methods have been reported for the detection of microcystins, but each has several cruc
drawbacks. The ELISA test has the promise of sensitivity and of rapid results, but the 
selectivity of the analysis is unknown, and could be subject to interferences from 
unrelated compounds. Analytic
ck here is the sensitivity and the lack of absolute quantification due to absorbance 
variability. Thus, while these methods provide some useful data, neither allows absolute
detection and quantification of these hepatotoxins. For these reasons a more definiti
analytical method is required. 
 Within this study, the detection and quantification of microcystins at sub-
 58
water supply samples through the use of LC/MS. This approach permits the identification
of indiv
 
idual microcystin derivatives within a complex mixture. In addition to the 
 of these toxins, the extraction and concentration of both water and 
 
ystins 
or 
l 
f 
s of 
found t east 
d. 
ification of the most 
common microcystins, 57 other known minor variants do exist. Currently, only six of the 
accurate monitoring
cell samples has been developed to quickly and effectively purify and concentrate the
microcystins present. The detection sensitivity of this method for the analysis of 
microcystins is 0.08 µg/ L, which is below the current allowable levels for microc
in drinking water currently in effect in many countries.  
The development of accurate calibration curves using LC/MS was necessary to 
allow quantification of natural samples. Accurate calibration curves were developed f
the more common microcystin derivatives: MCLR (35), MCRR (37), and MCYR (36) 
during this study. Each of these curves is accurate between the range of 2.3-400 µg/m
permitting the determination of toxin levels within this range. The efficiency of the 
extraction and concentration methods was optimized in order to remove the majority o
the unwanted compounds and concentrate the microcystins present within the limit
accurate quantification. In the case of natural water samples, the clean-up method was 
o extract microcystins from the water sample and concentrate to sample by at l
100-fold. Through the use of the detection and quantification methods developed within 
this work, the presence of microcystins and concentration determinations were able to 
accurately be determined. Within this study, virtually unambiguous detection of 
microcystins has been achieved allowing affective monitoring of drinking water supplies. 
 From the results obtained in this work, future research topics have been identifie
While the methods here allow for the easy detection and quant
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microcystin variants are com  the cost of these 
ompounds is prohibitive ($250/µg). The availability of microcystin standards would 
cilita
ccurate 
his 
ire the application of a pressure system, to rapidly push the water through 
 
te the 
 
he 
 it would greatly decrease the amount of time to run each 
ample
mercially available, and even then
c
fa te quantification of all the known variants, and frequent calibration checks of the 
equipment and analytical method. Consequently, the development of simple isolation 
methods for the major and minor microcystins is essential.  
Another area of interest evolves from the collection of samples from the field. 
Based on the amount of water that needs to be collected (approximately 1L) for a
analysis, it would be helpful to develop a method that permits concentration of water 
samples in the field. Such a method would require the development of solid phase 
extraction (SPE) cartridges, through which large volumes of water could be passed. T
would also requ
the cartridge. The benefit of this would be that instead of leaving collection sites with 
liters of water, only several convenient cartridges would be required. 
It may also be possible to shorten the length of each analytical run. An approach 
to reduce the length of the LC/MS method would be the development of an isocratic LC
system. Such a method was not found in the present studies that sufficiently separa
standards for quantification, there are still many chromatography variables that can be 
examined. There is also interest in the development of detection and quantification 
methods by MS alone, which would save time by circumventing the LC steps. While this
would result in a loss of checks and balances between the mass spectrometer scan and t
retention time of the standards,
s . While a method of this type would not be able to give accurate confirmation of 
the microcystins present, but this quick method would allow a way to determine which 
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samples need further testing by LC/MS. All of these techniques and procedures would 
further the efficiency of the methods found within these studies and enable easier 
detection of these toxins. 
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MICROCYSTIN CONCLUSIONS 
 Based on these results, a rapid and accurate method has been established for th
detection of microcystins using LC/MS techniques. The limit of detection for this method
was found to be 0.08 µg/L, which is more sensitive than the known allowable levels in
drinking water supplies. Further emphasis is found in the dev
e 
 
 
elopment of calibration 
curves 
 
for the most common microcystins enabling the determination of toxin 
concentration in water supplies. All of the procedures have lead to the unambiguous 
determination of the amount of microcystins present and differentiation of microcystin
variants. 
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Appendix 1: Composition of Vanillin/H2SO4 TLC Spray 
60 g vanillin 
1 L 95% ethanol 
ulfuric acid
 
 
10 ml s
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Appendix 2: Proton NMR Spectra of Tryptophol (22) 
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App 22) endix 3: Carbon and DEPT NMR Spectra of Tryptophol (
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Appendix 4: HMQC Spectra of Tryptophol (22) 
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Appendix 5: COSY NMR Spectra of Tryptophol (22) 
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Ap 2) 
 
pendix 6: TOCSY NMR Spectra of Tryptophol (2
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Appendix 7: Mass Spectrometer Conditions 
 
ES Source: 
 Voltages: 
  Capillary (kV)    3.5 
  Cone (V)    25 
  Extractor (V)    5 
  RF lens (V)    0.5 
 Temperatures: 
  Source     125 
  Desolvation    350 
 Gas flow: 
  Desolvation    350 
  Cone     50 
 
Analyser: 
 Analyser: 
  LM Resolution   15 
  HM Resolution   15 
  Ion Energy    0.5 
  Multiplier    650 
 Syringe: 
  Pump flow   10 microliter/min 
 
Mass Scan: 
 
Voltage 
Mass 
Range ES Mode
25 100-1200 ES+/ES- 
50 100-1200 ES+/ES- 
75 100-1200 ES+/ES- 
100 100-1200 ES+/ES- 
125 100-1200 ES+/ES- 
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ix 8: Mass Spectra of indole-3-aldehyde (23) at 25 V and
                                  
         
 
A:    Mass Spectrum at 25 V                           B:    Mass Spectrum at 75 V 
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 9: Mass Spectra of Tryptophol (22) at 25 V a
 
                             
           A:    Mass Spectrum at 25 V                           B:    Mass Spectrum at 75 V 
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pendix 10: Mass Spectra of indole-3-carboxylic acid (24) at 25 V and 75
                                
                  A:    Mass Spectrum at 25 V                        B:    Mass Spectrum at 75 V 
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Appendix  
 
 11: Mass Spectra of Unknown Metabolite (25) at 25 V and 75 V
                                  
 A:    Mass Spectrum at 25 V          B:    Mass Spectrum at 75 V 
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Appe
 
 
 
 
 
 
 
 
Reversed Phase Chromatography: 
  
  Column: Agilent Eclipse XDB-C18 
  Size: 4.6mm x 250 mm 
  Particle: 5µm 
  Flow rate: 1.0 ml/min 
  Gradient: 50-95% MeOH/0.1% TFA over 20 minutes 
  UV monitoring: 214nm, 238 nm 
 
 
Hydrophilic Liquid Interaction Chromatography: 
   
  Column: Tosoh Biosep Amide 80 
  Size: 2.0mm x 150mm 
  Particle: 5µm 
  Flow rate: 0.2 ml/min 
  Gradient:  
 
UV monitoring: 
 
 
 
 
 
 
ndix 12: Standard HPLC Methods for Normal and Reversed Phase Columns 
Time ACN/ 0.1% FA Water/ 0.1% FA
0 95 5
13 75 25
13.1 10 90
18 25 75
18.1 65 35
25 35 65
  214nm, 238nm 
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Appendix 13: Standard UV Spectrum of Microcystins 
 
 
 
 
 
 
 
nm220 240 260 280 300 320 340 360 380
mAU
0
50
100
150
200
*DAD1, 9.390 (231 mAU,Apx) Ref=0.004 & 17.417 of MCMIX
Standard UV Spectrum of Microcystins
UV Maximum at 238 nm
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Appendix 14: Mass Spectra of Microcystin Standards 
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